Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds MITPF.
No tracked institution reports a position in MITPF as of their last filing.
No one on the platform has traded MITPF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $155M | +42.5% | $0.62 | $0.62–$0.62 | 10.9× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| MITPFMithra Pharmaceuticals S.A. | $23.90 | +254.07% | $1.6B | — |
| BIESFBiotest AG | $32.00 | +0.00% | $1.6B | — |
| BITGFBiotage AB (publ) | $15.01 | +0.00% | $1.2B | — |
| CCHWFColumbia Care Inc. | $0.94 | -21.71% | $521M | — |
| CSWYFChina Shineway Pharmaceutical Group Limited | $1.00 | +0.00% | $758M | — |
| DWRKFDrägerwerk AG & Co. KGaA | $543.70 | +0.00% | $1.8B | — |
| KARBFKaro Pharma AB (publ) | $5.25 | +0.00% | $1.5B | — |
Source: Financial Modeling Prep · peers by sector/industry